Skip to content
healthcare.dev

TOFACITINIB CITRATE

NDC 50228-567, Tofacitinib citrate, tablet, film coated, extended release, from ScieGen Pharmaceuticals, INC..

Product NDC
50228-567
Status
Listed
Labeler
ScieGen Pharmaceuticals, INC.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220972
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-567 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE11 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
50228-567-10502280567101000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-567-10)
50228-567-305022805673030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-567-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/11d08738-efa3-4474-8eda-812bc04adfbb

Use it

Look up 50228-567 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-567 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-567. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.